Yıl: 2008 Cilt: 19 Sayı: 2 Sayfa Aralığı: 104 - 108 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey

Öz:
Amaç: SEN virus paranteral yolla bulaşır ve transfüzyon sonrası hepatite neden olabilir. Klinik önemi ve sıklığı kronik C ve B hepatitli hastalarda araştırılmıştır, ancak kronik D hepatitinde önemi bilinmemektedir. Bu çalışmada amaç Türkiye’de kronik C, B ve delta hepatitinde SEN virus-H sıklığı ve klinik önemini belirlemektir. Yöntem: Seksen beş kronik viral hepatitli hasta (30 HCV, 30 HBV ve 25 HDV) ve 43 sağlıklı kan vericisinde SEN virus-H araştırılmıştır. Hepatit B, C ve D hastaları nda sırasıyla HBV DNA, HCV RNA ve HDV RNA pozitif idi. SEN virus-H DNA’sı serumdan DNA ekstraksiyonu yapıldı ktan sonra (NucleoSpin blood; Macherey-Nagel GmbH & Co KG, Germany) seminested polimeraz zincir reaksiyonu ile (L2AS, C5S primer in first step, L2AS, D11 in second step) araştırılmıştır. Bulgular: SEN virus-H DNA pozitifliği, kronik C, B, D hepatitinde ve sağlıklı kan vericilerinde sırasıyla 7/30(23.3%), 10/30 (33.3%), 6/25(24%), 7/43(16.2%) olarak saptandı. Kronik viral hepatitli hastalarda, SEN virus-H pozitif ve negatif hastalar arasında klinik özellikler ve tedaviye cevap açısından farklılık saptanmadı. Sonuç: SEN virus kronik viral hepatitli hastalarda sağlıklı kan vericilerinden daha fazladır. Bu sonuçlar, SEN virusun kronik viral hepatitde tedavi cevabı ve klinik seyirde etkili olmadığı nı göstermektedir.
Anahtar Kelime: Hepatit B, kronik Kan vericileri DNA virüs enfeksiyonları Genotip Tedavi sonucu Torque teno virüs Eş tanı DNA, viral Hepatit D, kronik Yaygınlık Hepatit C, kronik gamma-glutamiltranferaz Aspartat aminotransferazlar Geriyedönük çalışma Alkalin fosfataz

Konular: Cerrahi

Türkiye’de kronik B, C ve D hepatit infeksiyonlarında SEN-H virüsünün klinik önemi ve sıklığı

Öz:
Background/aims: SEN viruses are transmitted parenterally and can cause post-transfusion hepatitis. The prevalence and clinical significance of SEN viruses have been investigated in patients with chronic hepatitis C and B but not in D. We aimed to determine the prevalence and clinical significance of SEN viruses- H in patients with chronic hepatitis C, B and delta in Turkey. Methods: SEN viruses-H was analyzed in 85 patients with chronic viral hepatitis (30 HCV, 30 HBV and 25 HDV) and 43 non-professional blood donors. HBV DNA, HCV RNA and HDV RNA were positive in patients with hepatitis B, C and D, respectively. SEN viruses-H DNA was detected by semi-nested polymerase chain reaction method (L2AS, C5S primer in first step, L2AS, D11 in second step) after extraction of DNA from sera (NucleoSpin blood; Macherey-Nagel GmbH & Co KG, Germany). Results: SEN viruses-H DNA was found to be positive in 7/30 (23.3%), 10/30 (33.3%), 6/25 (24%), and 7/43 (16.2%) of patients with chronic C, B, and D hepatitis and healthy blood donors, respectively. There was no significant difference in clinical features and treatment response between SEN viruses- H-positive and -negative patients with chronic viral hepatitis. Conclusions: SEN viruses is more frequent in chronic hepatitis patients than in healthy blood donors. These results indicate that SEN viruses has no effect on the clinical course and treatment response of chronic viral hepatitis.
Anahtar Kelime: Comorbidity DNA, Viral Hepatitis D, Chronic Prevalence Hepatitis C, Chronic gamma-Glutamyltransferase Aspartate Aminotransferases Retrospective Studies Alkaline Phosphatase Hepatitis B, Chronic Blood Donors DNA Virus Infections Genotype Treatment Outcome Torque teno virus

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Umemura T, Yeo AE, Sottini A, et al. SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 2001; 33: 1303-11.
  • 2. Shibata M, Wang RY, Yoshiba M, et al. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan. J Infect Dis 2001; 184: 400-4.
  • 3. Kao JH, Chen W, Chen PJ, et al. Prevalence and implication of a newly identified infectious agent (SEN virus) in Taiwan. J Infect Dis 2002; 185: 389-92.
  • 4. Akiba J, Umemura T, Alter HJ, et al. SEN virus: epidemiology and characteristics of a transfusion-transmitted virus. Transfusion 2005; 45: 1084-8.
  • 5. Umemura T, Alter HJ, Tanaka E, et al. SEN virus: response to interferon alpha and influence on the severity and treatment response of coexistent hepatitis C. Hepatology 2002; 35: 953-9.
  • 6. Jardi R, Rodrigez F, Buti M, et al. Role of hepatitis B, C and D viruses in dual and triple infections: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001; 34: 404-10.
  • 7. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
  • 8. Boom R, Sol CJ, Salimans MM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 18: 495-503.
  • 9. Niro GA, Smedile A, Andriulli A, et al. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology 1997; 25: 728-34.
  • 10. Ivaniushina V, Radjef N, Alexeeva M, et al. Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia. J Gen Virol 2001; 82: 2709-18.
  • 11. Schröter M, Laufs R, Zollner B, et al. Prevalence of SENVH viraemia among healthy subjects and individual risk for parenterally transmitted diseases in Germany. J Viral Hepat 2002; 9: 455-9.
  • 12. Kaymakoglu S, Karaca C, Demir K, et al. Alpha interferon and ribavirin combination therapy of chronic hepatitis D. Antimicrob Agents Chemother 2005; 49: 1135-8.
  • 13. Yoshida EM. Is there an association between SEN virus and liver disease? Reviewing the evidence. Can Commun Dis Rep 2002; 28: 53-60.
  • 14. Mu SJ, Du J, Zhan LS, et al. Prevalence of a newly identified SEN virus in China. World J Gastroenterol 2004; 10: 2402-5.
  • 15. Huang LR, Wang HH, Lin WS, Lin CL. The prevalence of SEN virus infection in blood donors in Taiwan. J Infect 2005; 51: 30-4.
  • 16. Primi D, Fiordalisi G, Mantero JL, et al. Identification of SENV genotypes: international publication number WO0028039. Available at:http://ep.espacenet.com/
APA ÇAKALOĞLU Y, Akyuz F, BOZACI M, İBRİŞİM D, PINARBAŞI B, Demir K, Kaymakoglu S, Beşışık F, Badur s, ÖKTEN A (2008). Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey. , 104 - 108.
Chicago ÇAKALOĞLU Yılmaz,Akyuz Filiz,BOZACI Mürvet,İBRİŞİM Duygu,PINARBAŞI Binnur,Demir Kadir,Kaymakoglu Sabahattin,Beşışık Fatih,Badur selim,ÖKTEN Atilla Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey. (2008): 104 - 108.
MLA ÇAKALOĞLU Yılmaz,Akyuz Filiz,BOZACI Mürvet,İBRİŞİM Duygu,PINARBAŞI Binnur,Demir Kadir,Kaymakoglu Sabahattin,Beşışık Fatih,Badur selim,ÖKTEN Atilla Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey. , 2008, ss.104 - 108.
AMA ÇAKALOĞLU Y,Akyuz F,BOZACI M,İBRİŞİM D,PINARBAŞI B,Demir K,Kaymakoglu S,Beşışık F,Badur s,ÖKTEN A Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey. . 2008; 104 - 108.
Vancouver ÇAKALOĞLU Y,Akyuz F,BOZACI M,İBRİŞİM D,PINARBAŞI B,Demir K,Kaymakoglu S,Beşışık F,Badur s,ÖKTEN A Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey. . 2008; 104 - 108.
IEEE ÇAKALOĞLU Y,Akyuz F,BOZACI M,İBRİŞİM D,PINARBAŞI B,Demir K,Kaymakoglu S,Beşışık F,Badur s,ÖKTEN A "Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey." , ss.104 - 108, 2008.
ISNAD ÇAKALOĞLU, Yılmaz vd. "Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey". (2008), 104-108.
APA ÇAKALOĞLU Y, Akyuz F, BOZACI M, İBRİŞİM D, PINARBAŞI B, Demir K, Kaymakoglu S, Beşışık F, Badur s, ÖKTEN A (2008). Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey. Turkish Journal of Gastroenterology, 19(2), 104 - 108.
Chicago ÇAKALOĞLU Yılmaz,Akyuz Filiz,BOZACI Mürvet,İBRİŞİM Duygu,PINARBAŞI Binnur,Demir Kadir,Kaymakoglu Sabahattin,Beşışık Fatih,Badur selim,ÖKTEN Atilla Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey. Turkish Journal of Gastroenterology 19, no.2 (2008): 104 - 108.
MLA ÇAKALOĞLU Yılmaz,Akyuz Filiz,BOZACI Mürvet,İBRİŞİM Duygu,PINARBAŞI Binnur,Demir Kadir,Kaymakoglu Sabahattin,Beşışık Fatih,Badur selim,ÖKTEN Atilla Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey. Turkish Journal of Gastroenterology, vol.19, no.2, 2008, ss.104 - 108.
AMA ÇAKALOĞLU Y,Akyuz F,BOZACI M,İBRİŞİM D,PINARBAŞI B,Demir K,Kaymakoglu S,Beşışık F,Badur s,ÖKTEN A Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey. Turkish Journal of Gastroenterology. 2008; 19(2): 104 - 108.
Vancouver ÇAKALOĞLU Y,Akyuz F,BOZACI M,İBRİŞİM D,PINARBAŞI B,Demir K,Kaymakoglu S,Beşışık F,Badur s,ÖKTEN A Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey. Turkish Journal of Gastroenterology. 2008; 19(2): 104 - 108.
IEEE ÇAKALOĞLU Y,Akyuz F,BOZACI M,İBRİŞİM D,PINARBAŞI B,Demir K,Kaymakoglu S,Beşışık F,Badur s,ÖKTEN A "Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey." Turkish Journal of Gastroenterology, 19, ss.104 - 108, 2008.
ISNAD ÇAKALOĞLU, Yılmaz vd. "Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey". Turkish Journal of Gastroenterology 19/2 (2008), 104-108.